[EATG Global HIV News daily digest] Digest #16-2010

[EATG Global HIV News daily digest]

Global HIV News Daily Digest

Copied as fair use  -  Ana  -






  




Latest Headlines




  Abbott submits new HIV test to FDA for expedited review
  Prevention Thursday 28 January 2010
					
  
Upon approval, the assay is expected to be the first test available in
the United States to simultaneously detect the combined presence of HIV
antigens and antibodies, which would allow for the early detection and
ongoing monitoring of the virus.
  SOURCE:
Abbott




  Gates says malaria vaccine may be ready in three years 
  Tuberculosis & Malaria Thursday 28 January 2010
					
  
Microsoft founder Bill Gates has told the BBC that a vaccine for malaria could be just three years away.
  SOURCE:
BBC News




  Lab-grown liver cells provide model for hepatitis C infection
  Hepatitis Thursday 28 January 2010
					
  
Researchers have developed a new method for growing human liver cells
outside the body. Scientists can now study hepatitis C virus in the lab
over a period of weeks – which may boost efforts to develop a vaccine
or broadly effective treatment for the infection. 
  SOURCE:
HHMI




  Gilead profit rises on sales of AIDS pills, flu drug 
  Pharma Industry Thursday 28 January 2010
					
  
Gilead Sciences Inc. said fourth-quarter profit jumped 43 percent on
demand for AIDS drugs and surging royalties from the anti-flu treatment
Tamiflu.
  SOURCE:
BusinessWeek




  Achillion pharma at a glance
  Hepatitis Thursday 28 January 2010
					
  
Achillion's product pipeline includes ACH-1625 and ACH-1095 for the
treatment of chronic hepatitis C infection; ACH-702 for the treatment
of serious, resistant bacterial infections and Elvucitabine for the
treatment of HIV.
  SOURCE:
TradingMarkets.com




  European Medicines Agency launches consultation on its Road Map to 2015
  EMEA & FDA Thursday 28 January 2010
					
  
New strategic vision continues previous Road Map initiative, setting out the Agency’s priorities for the next five years.
  SOURCE:
EMEA




  Under scrutiny, WHO, pharma seek to explain "dangerous nonsense" of pandemic
  World Policy Thursday 28 January 2010
					
  
Representatives of the World Health Organization and the European
pharmaceutical industry answered charges from the Council of Europe and
the press on whether they had mishandled an outbreak of influenza last
summer.
  SOURCE:
Intellectual Property Watch




  UCF professor's vaccine could be lethal weapon against malaria, cholera
  Tuberculosis & Malaria Wednesday 27 January 2010
					
  
Mankind may finally have a weapon to fight two of the world's deadliest diseases. 
  SOURCE:
EurekAlert!




  Dynavax hepatitis C drug shows promise in phase 1 trial
  Hepatitis Wednesday 27 January 2010
					
  
Drug SD-101 was safe and showed anti-viral response.
  SOURCE:
REUTERS




  FDA review of HIV lipodystrophy drug is delayed
  Treatment Wednesday 27 January 2010
					
  
Originally scheduled for Wednesday, February 24, the meeting of the
Endocrinologic and Metabolic Drugs Advisory Committee is being delayed
for procedural reasons, Theratechnologies reports, not because of
concerns surrounding tesamorelin’s safety or efficacy.
  SOURCE:
AIDSmeds.com




  Genetic marker predicts fat loss due to d4T in Thai patients 
  Treatment Wednesday 27 January 2010
					
  
A genetic marker can predict with a high level of accuracy whether Thai
patients receiving antiretroviral therapy that contains d4T will
develop lipoatrophy as a result of treatment.
  SOURCE:
Aidsmap




  Poor kidney function increases cardiovascular disease risk for patients with HIV
  Treatment Wednesday 27 January 2010
					
  
Poor kidney function is associated with an increased risk of
cardiovascular disease in patients with HIV, US investigators report in
the January 28th edition of AIDS. 
  SOURCE:
Aidsmap


----------------------------------------------------
DISCLAIMER
The articles in this digest represent a diversity of opinions on topics
of interest to the HIV treatment activist community. The EATG is not
responsible for their content. The articles posted in this digest do
not necessarily reflect EATG views or opinions.
FAIR USE NOTICE
The digest may contain copyrighted material which has not always been
specifically authorised by the copyright owner. Such material is made
available for educational purposes to advance the understanding of
scientific, ethical, legal and social issues. It is believed that this
constitutes a 'fair use' of any such copyrighted material. This
material is distributed without profit.


 

Information in this digest was accurately quoted during its compilation.




      
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mail.eatg.org/pipermail/eatg-forum_eatg.org/attachments/20100127/6a1ac4d3/attachment-0001.html>